title: Ivabradine for the treatment of stable angina pectoris in octogenarians.
abstract: OBJECTIVE
  In patients >80 years (octogenarians), there is an increased incidence of bradycardia due to age-related alteration of the sinus node, AV node, and the conduction system. Therefore, the treatment of angina pectoris with beta-blockers may be limited by bradycardia. The REDUCTION multicenter study evaluated the efficacy of ivabradine in stable angina pectoris in everyday practice. This subgroup analysis evaluated the efficacy and safety of ivabradine in octogenarians.
  
  
  METHODS
  A total of 4,954 patients were included in the REDUCTION study for treatment of stable angina pectoris. This group included 382 octogenarians (mean age 83 ± 2.9 years) who were followed up over 4 months. Patients were treated with ivabradine in flexible doses (2.5, 5, or 7.5 mg bid). Heart rate (HR), angina pectoris attacks, nitrate consumption, overall efficacy, and tolerance were evaluated.
  
  
  RESULTS
  After 4 months of treatment with ivabradine, HR was reduced by 12.0 ± 12.0 bpm from 83.0 ± 15.4 to 71.0 ± 10.1 bpm (p < 0.0001). Angina pectoris attacks were reduced from 3.0 ± 4.6 to 0.8 ± 1.8 per week (p < 0.0001). Consumption of nitrates decreased from 4.2 ± 5.1 to 1.2 ± 2.7 (p < 0.0001). Four patients reported suspected adverse drug reactions. In one patient a syncope occurred. There was no symptomatic bradycardia reported. Efficacy and tolerance were assessed as 'very good/good' for 95 and 99%.
  
  
  CONCLUSIONS
  The results demonstrate that ivabradine efficiently reduces HR, number of angina attacks, and nitrate consumption in octogenarian patients. The treatment was safe and well tolerated without relevant bradycardia.
authors.affiliation: Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany. rkoester@uke.uni-hamburg.de
authors.forename: Ralf
authors.initials: R
authors.lastname: Koester
authors.forename: Jan
authors.initials: J
authors.lastname: Kaehler
authors.forename: Thomas
authors.initials: T
authors.lastname: Meinertz
mesh_terms: D000369:Aged, 80 and over; D000787:Angina Pectoris / Q000188:drug therapy* / Q000453:epidemiology*; D001552:Benzazepines / Q000627:therapeutic use*; D001919:Bradycardia / Q000453:epidemiology*; D015897:Comorbidity; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D005260:Female; D006801:Humans; D015994:Incidence; D000077550:Ivabradine; D008297:Male
chemical_list: D001552:Benzazepines; D000077550:Ivabradine
references.citation: Am Heart J. 2010 Apr;159(4):508-517.e1
references.pmid: 20362707
references.citation: JAMA. 1992 Sep 16;268(11):1417-22
references.pmid: 1512909
references.citation: Clin Res Cardiol. 2007 Sep;96(9):585-92
references.pmid: 17593316
references.citation: N Engl J Med. 2000 Jun 22;342(25):1907-9
references.pmid: 10861329
references.citation: Eur Heart J. 2006 Jun;27(11):1341-81
references.pmid: 16735367
references.citation: Circulation. 1976 Sep;54(3):522-3
references.pmid: 947585
references.citation: Z Kardiol. 2003 Jun;92(6):501-21
references.pmid: 12905980
references.citation: Clin Res Cardiol. 2010 Oct;99(10):665-72
references.pmid: 20454968
references.citation: Eur Heart J. 2005 Dec;26(23):2529-36
references.pmid: 16214830
references.citation: N Engl J Med. 2000 Jun 22;342(25):1887-92
references.pmid: 10861325
references.citation: Circulation. 1967 Jun;35(6):1073-83
references.pmid: 6026199
references.citation: Clin Res Cardiol. 2006 Jul;95(7):360-7
references.pmid: 16741630
references.citation: Clin Res Cardiol. 2009 Aug;98(8):477-86
references.pmid: 19479183
references.citation: J Am Coll Cardiol. 2007 Aug 28;50(9):823-30
references.pmid: 17719466
references.citation: Sci Am. 1977 Oct;237(4):132-40
references.pmid: 905817
references.citation: Circulation. 2007 Dec 4;116(23):2762-72
references.pmid: 17998462
references.citation: Eur Heart J. 2009 Oct;30(19):2337-45
references.pmid: 19720635
references.citation: Clin Res Cardiol. 2011 Jan;100(1):29-36
references.pmid: 20644943
references.citation: Eur Heart J. 1999 Dec;20(24):1791-8
references.pmid: 10581137
references.citation: Circulation. 1991 Apr;83(4):1263-70
references.pmid: 1901527
references.citation: Clin Res Cardiol. 2008 Nov;97(11):811-9
references.pmid: 18648727
references.citation: Clin Res Cardiol. 2008 Sep;97(9):575-7
references.pmid: 18536866
references.citation: Lancet. 2008 Sep 6;372(9641):807-16
references.pmid: 18757088
references.citation: Eur Heart J. 2009 Mar;30(5):540-8
references.pmid: 19136486
references.citation: Circulation. 2003 Feb 18;107(6):817-23
references.pmid: 12591750
references.citation: Drugs. 2004;64(16):1757-65
references.pmid: 15301560
references.citation: Cardiol Clin. 1999 Feb;17(1):17-34
references.pmid: 10093763
references.citation: Am Heart J. 2009 Oct;158(4):e51-7
references.pmid: 19781403
references.citation: Lancet. 2008 Sep 6;372(9641):817-21
references.pmid: 18757091
references.citation: JAMA. 2001 Aug 8;286(6):708-13
references.pmid: 11495621
references.citation: Cardiology. 2009;114(2):116-25
references.pmid: 19468225